Panacea Biotec Limited (BOM:531349)
India · Delayed Price · Currency is INR 363.80
+14.45 (4.14%)
At close: Oct 6, 2026
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 22.25 billion as of October 7, 2026. Its market cap has decreased by -12.53% in one year.
Market Cap
22.25B
Enterprise Value
21.68B
Revenue
6.73B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has increased from 21.08B to 22.25B, an increase of 5.55%. That is a compound annual growth rate of 0.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 22.25B | -3.48% |
| Dec 31, 2025 | 23.05B | -10.11% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 38.52B |
| Hester Biosciences | 18.21B |
| Titan Biotech | 16.18B |
| Zenotech Laboratories | 2.56B |
| CCME Global | 1.88B |
| Bharat Immunologicals & Biologicals Corporation | 353.21M |
| Transgene Biotek | 181.85M |
| Hindustan Bio Sciences | 75.34M |